ea0020p381 | Diabetes and Cardiovascular | ECE2009
Ilic Sanja
, Kostic Nada
, Caparevic Zorica
, Radojkovic Jana
, Jelic Svetlana
, Marina Djordje
Background and aims: Plasminogen activator inhibitor -1 (PAI-1) increases in diabetes and this might contribute to decreased fibrinolisis and accelerated atherosclerosis. PAI-1 is also contributor to the development of acute myocardial infarction. Measurement of intimal medial thickening (IMT) is indicator of presence and extent of coronary artery disease. Aim of the study was to find association between PAI-1 marker of decreased fibrinolisis and atherosclerosis by measuring I...